Acute Myeloid Leukemia

Treatment with an all-oral regimen led to three-year overall survival and relapse-free survival rates of 97% in patients with acute promyelocytic leukemia, a subset of acute myeloid leukemia.

As Billy Bean, MLB VP, revealed a cancer diagnosis and Toronto Blue Jays sportscaster, Jamie Campbell showed pre-skin cancer photo, here is what’s happening in the oncology space this week.

Patience is key when supporting a patient with cancer.

In honor of National Family Caregiver’s Month, CURE® highlights some of the most important news in 2023.

Here's what I was asked during an AML patient workshop...

Maintenance treatment with Nexavar improved survival in patients with FLT3-ITD acute myeloid leukemia, research showed.

My donor is at war.

After experiencing a relapse of acute myeloid leukemia, I thought about giving up, but then remembered my guiding principles.

Somehow, despite our best intentions and efforts, life throws us curveballs.

In the recent AUGMENT-101 trial, revumenib met the study goals of complete remission in patients with acute myeloid leukemia or acute lymphoid leukemia.

A new Phase 1B/2 trial treated patients with acute myeloid leukemia (AML) in a drug regimen combination of Annamycin and Ara-C.

For Maggie Cambora, who received a diagnosis of acute myeloid leukemia in 2020, the third potential donor match was the connection that saved her life, she told CURE®.

“Full-time mom, full-time hairdresser, full-time wife” Maggie Cambora, who received a diagnosis of acute myeloid leukemia in 2020, received a stem cell transplant.

Patients with acute myeloid leukemia who took vitamin C and D supplements experienced fewer complications, but no overall survival benefits.

Elderly patients with acute myeloid leukemia did not experience a difference in relapse-free survival or non-relapse mortality with intensive versus non-intensive chemotherapy.

Sitting vigil next to an end-of-life patient.

From a former patient with cancer lives her dream of working alongside her doctor, to NASCAR crew chief Tommy Baldwin Jr. announcing his cancer diagnosis, this is what’s going on in the oncology space this week.

Enjoying things right in front of me.

Patients with a subset of acute myeloid leukemia may have improved survival rates and lower risk of relapse with Nexavar maintenance.

The Food and Drug Administration approved a Vanflyta regimen for patients with FLT-ITD—positive acute myeloid leukemia.

After recovering from a bone marrow transplant to tackle a recurrence of acute myeloid leukemia, I started to volunteer.

I couldn't believe that I would benefit from some of the side effects of my cancer treatment.

I have a confession: I daydreamed of a “last hurrah” should my cancer treatment not work.

After two diagnoses of acute myeloid leukemia, intense chemo and a bone marrow transplant, I’ve learned some things that helped me along the way.

Findings from a phase 3 trial demonstrated that half of patients with FLT3-ITD-mutant acute myeloid leukemia and detectable minimal residual risk derived a relapse-free survival benefit with Xospata.

Iclusig plus reduced-intensity chemotherapy led to improved outcomes for patients with Philadelphia chromosome (Ph)–positive acute lymphoblastic leukemia, and should be the new standard of care, one expert said.

Lasting guilt gets no one anywhere — especially when it comes to cancer.

Acute myeloid leukemia and myelodysplastic syndrome may affect nutritional status, and more work is needed to ensure that patients are getting the food intake that they need, researchers found.

Looking back on my experiences with leukemia and with alcoholism, I realized that the 12 steps of Alcoholics Anonymous can be applied to life with cancer.

A decade ago, I was diagnosed with acute myeloid leukemia and underwent aggressive chemotherapy and an allogenic stem cell transplant. Though I still have complications related to my cancer, I’m thankful for what I still have.